Significant Ownership of Clearline Capital LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Clearline Capital LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Marc Majzner - Limited Partner
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Clearline Capital LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Clearline Capital LP
Significant Ownership of Clearline Capital LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Common Stock, par value $0.01 per share | 6.7% | $18,108,154 | +$3,733,614 | 12,235,239 | +26% | Clearline Capital LP | 31 Dec 2025 |
| XPER | Xperi Inc. | Common Stock (par value $0.001 per share) | 6.4% | $17,787,867 | 2,949,895 | Clearline Capital LP | 31 Dec 2025 | ||
| TXMD | TherapeuticsMD, Inc. | Common Stock, par value $0.001 per share | 5.5% | $705,096 | 635,222 | Clearline Capital LP | 31 Dec 2024 | ||
| MX | MAGNACHIP SEMICONDUCTOR Corp | Common Stock, par value $0.01 per share | 4.1% | $3,725,642 | -$1,119,807 | 1,461,036 | -23% | Clearline Capital LP | 31 Dec 2025 |
Schedules 13D/G Reported by Clearline Capital LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.